Emerging research suggest Retatrutide , a dual activator targeting both the gut-brain axis and another hormone, may offer a notable step forward for weight management . Initial human tests have indicated more info impressive reductions in visceral tissue, potentially exceeding other weight-loss therapies . Despite this, more assessment is required